Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
16 Results for "
menopausal symptoms
" in MedChemExpress (MCE) Product Catalog:
Products (16)
16 Results for "menopausal symptoms" in MCE Product Catalog:
9
9 Cited Publications
Synonyms: Ethynyl estradiol; 17α-Ethynylestradiol
Category:
Synonyms: NT-814; BAY3427080
Target:
Research Areas:
Elinzanetant is an orally active and selective NK-1 and NK-3 receptor antagonist. Elinzanetant alleviates menopause-associated vasomotor symptoms, including hot flashes and night sweats. Elinzanetant reduces estradiol and progesterone levels. Elinzanetant can be used for the research of moderate to severe vasomotor and sleep disorders associated with menopause .
Synonyms: MT-8554
Target:
Research Areas:
Cardiovascular Disease Neurological Disease Metabolic Disease
Elismetrep (MT-8554) is a TRPM8 channel antagonist and neuroprotective agent. Elismetrep is used for research on pain, menopause-related vasomotor symptoms, and diabetic peripheral neuropathy .
Synonyms: (±)-Veralipride; LIR166
Target:
Research Areas:
Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Target:
Research Areas:
Estradiol acetate is a novel orally active Estradiol (HY-B0141) prodrug. Estradiol acetate reduces the frequency and severity of postmenopause symptoms. Estradiol acetate can be used in the research of menopausal symptoms .
Cat. No.: HY-106827
CAS No.: 74513-62-5
Synonyms: RU 27987
Research Areas:
Trimegestone (RU 27987) is an orally active, selective progestogen and PR ligand, with an IC50 of 7.6 nM for hPR, 4.4 nM for rabbit PR, and 3.3 nM for rat PR. Trimegestone induces Alkaline phosphatase activity. Trimegestone exhibits antiandrogenic activity (IC50 = 303 nM). Trimegestone can be used in research related to menopausal symptoms and osteoporosis .
Cat. No.: HY-109171R
CAS No.: 929046-33-3
Synonyms: NT-814 (Standard); BAY3427080 (Standard)
Research Areas:
Elinzanetant (NT-814) Standard is the analytical standard of Elinzanetant (NT-814) (HY-109171). This product is intended for research and analytical applications. Elinzanetant is an orally active and selective NK-1 and NK-3 receptor antagonist. Elinzanetant alleviates menopause-associated vasomotor symptoms, including hot flashes and night sweats. Elinzanetant reduces estradiol and progesterone levels. Elinzanetant can be used for the research of moderate to severe vasomotor and sleep disorders associated with menopause .
Cat. No.: HY-N11787
CAS No.: 84776-26-1
Target:
Cat. No.: HY-101797R
CAS No.: 66644-81-3
Synonyms: (±)-Veralipride (Standard); LIR166 (Standard)
Target:
Research Areas:
Veralipride (Standard) is the analytical standard of Veralipride. This product is intended for research and analytical applications. Veralipride is a D2 receptor antagonist. It is an alternative antidopaminergic treatment for menopausal symptoms.
Cat. No.: HY-N8366
CAS No.: 35214-83-6
Target:
Cat. No.: HY-135593
CAS No.: 183060-99-3
Target:
Research Areas:
LY88074 analog 1 is a benzothiophene compound with nitrogen-containing non-basic side chains, Compound 26, extracted from patent EP0747380A1. LY88074 analog 1 is an agent for alleviating the symptoms of post-menopausal symptoms, such as osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer. LY88074 analog 1 can be used alone or in combination with estrogen or progestin .
Cat. No.: HY-109171S
Synonyms: NT-814-d3; BAY3427080-d3
Cat. No.: HY-10427A
CAS No.: 1214914-38-1
Synonyms: iso-NRI-022
Research Areas:
iso-WAY-260022 (Compound 13R) is an orally active, brain-penetrant and selective norepinephrine transporter (hNET) inhibitor with an IC50 value of 140 nM. iso-WAY-260022 also shows inhibitory effects on human serotonin (hSERT) and dopamine transporters (hDAT). iso-WAY-260022 inhibits norepinephrine reuptake and increases hypothalamic norepinephrine levels to regulate thermoregulatory center function. iso-WAY-260022 is promising for research of vasomotor symptoms, such as menopausal hot flushes, night sweats .
Cat. No.: HY-107906
CAS No.: 12126-59-9
Target:
Research Areas:
Conjugated estrogen sodium is a medication composed of a blend of estrogen hormones, utilized in the treatment of moderate to severe hot flashes, vaginal changes, and various other symptoms associated with menopause or decreased estrogen levels.
Cat. No.: HY-117076A
CAS No.: 61665-15-4
Synonyms: (R)-R 2858; RU 16117
Target:
Research Areas:
(R)-Moxestrol ((R)-R 2858; RU 16117) is an orally active weak partial agonist-antagonist of estrogen receptor (ER). (R)-Moxestrol binds to estrogen receptor to form a rapidly dissociating complex, reduces the levels of estrogen and prolactin receptor, exerts weak estrogenic effects at low doses, and displays anti-estrogenic effects at high doses or when competing with Estradiol (E2) (HY-B0141). (R)-Moxestrol can be used in research related to breast cancer and postmenopausal estrogen deficiency (menopausal symptoms, severe osteoporosis) .
Cat. No.: HY-N21981
CAS No.: 87095-76-9
Category:
Simple Phenylpropanols Scrophulariaceae Phenylpropanoids Plants Bacopa monnieri (Linn.) Wettst. Zingiberaceae Curcuma comosa Roxb.
Target:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
